High PriorityDeveloping
Ivermectin: A Controversial Choice Among Cancer Patients
high consequenceUpdated 1h ago
Key takeaway: The rising preference for ivermectin among cancer patients underscores a growing distrust in conventional treatments and highlights urgent needs for clear communication from the medical community.